DBV TECHNOLOGIES (EPA:DBV)

BRIEF

published on 09/23/2024 at 22:35, 1 month 27 days ago

DBV Technologies Completes Screening of Subjects for Phase 3 VITESSE Clinical Trial

Clinical Trial Phase 3 DBV Technologies Viaskin Peanut Peanut Allergy
BRIEF

published on 09/23/2024 at 22:35, 1 month 27 days ago

DBV Technologies clôture le screening des sujets de l'essai clinique de phase 3 VITESSE

Essai Clinique Phase 3 DBV Technologies Viaskin Peanut Allergie Arachide
PRESS RELEASE

published on 09/23/2024 at 22:30, 1 month 27 days ago

DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial
DBV Technologies completes screening for VITESSE Phase 3 Clinical Trial evaluating Viaskin Peanut Patch in peanut allergic children ages 4-7. Topline results expected Q4 2025

Clinical Trial DBV Technologies Food Allergies VITESSE Phase 3 Viaskin Peanut Patch
PRESS RELEASE

published on 09/23/2024 at 22:30, 1 month 27 days ago

DBV Technologies clôture le screening des sujets de l'essai clinique de phase 3 VITESSE
DBV Technologies achève le screening des participants à l'essai clinique de phase 3 VITESSE évaluant le patch Viaskin® Peanut chez les enfants allergiques à l'arachide. Premiers résultats attendus en 2025

Essai Clinique DBV Technologies Enfants Allergie Alimentaire Viaskin Peanut
BRIEF

published on 09/04/2024 at 22:35, 2 months 16 days ago

DBV Technologies participera à la 26e conférence annuelle H.C. Wainwright Global Investment

DBV Technologies Allergies Alimentaires Viaskin Conférence H.C. Wainwright Immunothérapie Épicutanée
BRIEF

published on 09/04/2024 at 22:35, 2 months 16 days ago

DBV Technologies to Participate in 26th Annual HC Wainwright Global Investment Conference

DBV Technologies Viaskin Food Allergies HC Wainwright Lecture Epicutaneous Immunotherapy
PRESS RELEASE

published on 09/04/2024 at 22:30, 2 months 16 days ago

DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
DBV Technologies to participate in H.C. Wainwright 26th Annual Global Investment Conference with CEO Daniel Tassé in New York City. Focus on food allergy treatment and immunotherapy

Immunotherapy DBV Technologies Food Allergies H.C. Wainwright Conference VIASKIN Patch
PRESS RELEASE

published on 09/04/2024 at 22:30, 2 months 16 days ago

DBV Technologies participera à la 26e conférence annuelle H.C. Wainwright Global Investment
DBV Technologies participera à la 26e conférence annuelle H.C. Wainwright Global Investment avec Daniel Tassé, Directeur Général, discutant lors d'une session 'Fireside Chat' à New York

Biopharmaceutique Conférence Annuelle DBV Technologies Allergies Alimentaires Investissement Global
BRIEF

published on 08/02/2024 at 22:35, 3 months 18 days ago

DBV Technologies : Informations au 31 juillet 2024 sur le nombre d'actions et de droits de vote

Droits De Vote Capital Social AMF DBV Technologies NYSE Euronext Paris
BRIEF

published on 08/02/2024 at 22:35, 3 months 18 days ago

DBV Technologies: Information as of July 31, 2024 on the number of shares and voting rights

Share Capital Voting Rights AMF DBV Technologies NYSE Euronext Paris

Published on 11/21/2024 at 16:30, 43 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 1 hour 12 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 1 hour 13 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 16:00, 1 hour 13 minutes ago

Wiz Acquires Dazz to Revolutionize Cloud Security Remediation
Published on 11/21/2024 at 16:00, 1 hour 13 minutes ago

Isaac Ullatil Joins Wellstack Board of Directors

View all ACCESSWIRE

Published on 11/21/2024 at 17:06, 7 minutes ago

Original-Research: PORR AG (von Montega AG): Kaufen
Published on 11/21/2024 at 17:02, 11 minutes ago

Original-Research: SBF AG (von Montega AG): Kaufen
Published on 11/21/2024 at 17:01, 12 minutes ago

Original-Research: Delticom AG (von Montega AG): Kaufen
Published on 11/21/2024 at 16:00, 1 hour 13 minutes ago

Director/PDMR Shareholding
Published on 11/21/2024 at 15:41, 1 hour 31 minutes ago

Edison issues report on Murray Income Trust (MUT)

View all EQS

Published on 11/21/2024 at 06:58, 10 hours 15 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 10 hours 15 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 10 hours 15 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 21 hours 5 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 21 hours 53 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE

News